NIH-funded research R01 grant

Understanding how certain immune cells help heal lung blood vessels after injury

Official title: Perivascular macrophages - a new player in regulating endothelial repair following lung vascular injury

Funded at University of Illinois at Chicago · NIH-11293386 · Data updated 2026-11-12

This study is looking at how certain immune cells in the lungs help repair blood vessels after a serious lung injury called Acute Respiratory Distress Syndrome (ARDS), and it aims to find new ways to improve recovery for patients with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startJune 15, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$432,891
NIH project number5R01HL169447-02
Project IDNIH-11293386 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Acute Respiratory Distress Syndrome or those experiencing severe acute lung injury.

Less likely to help

Patients with chronic lung conditions or those not experiencing acute lung injury may not benefit from this research.

What this research studies

This research investigates the role of perivascular macrophages (PVMs) in the healing process of lung blood vessels following acute lung injury, specifically Acute Respiratory Distress Syndrome (ARDS). By using advanced imaging techniques, the study will observe how these immune cells interact with endothelial cells in live mouse models. The researchers will manipulate the presence of PVMs to understand their impact on blood vessel repair and regeneration. This could lead to new therapeutic strategies aimed at enhancing lung recovery in patients suffering from ARDS.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that significantly improve recovery outcomes for patients with ARDS.

How similar studies have gone: While the role of macrophages in lung repair is being explored, this specific focus on perivascular macrophages in ARDS is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Zhou, Bisheng — University of Illinois at Chicago
  • Study coordinator: Zhou, Bisheng

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.